Insulin-like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women

Calcified Tissue International

Volumn 71, Issue 4, 2002, Pages 323-328

  Karasik, D ^a   Rosen, C J ^b   Hannan, M T ^a   Broe, K E ^a   Dawson Hughes, B ^c   Gagnon, D R ^d   Wilson, P W F ^e   Visser, M ^f   Langlois, J A ^g   Mohan, S ^h   Kiel, D P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ST JOSEPH HOSPITAL   (United States)

^c TUFTS UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

Aged; Bone mineral density; IGF I binding protein 4; IGF I binding protein 5; Insulin like growth factor 1; Serum

Indexed keywords

ESTROGEN; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BONE DENSITY; BONE MASS; BONE MINERAL; COHORT ANALYSIS; DRUG USE; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIODENSITOMETRY; RADIOIMMUNOASSAY; SEX DIFFERENCE; SMOKING; BLOOD; FEMUR; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; FEMUR; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 0036782543     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-1002-0     Document Type: Article

References (27)

1. Honda Y, Landale E, Strong D, Baylink D, Mohan S (1996) Recombinant synthesis of insulin-like growth factor binding protein-4 (IGFBP-4): development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab 81:1389-1396
2. Canalis E (1994) Skeletal growth factors and aging (editorial). J Clin Endocrinol Metab 78:1009-1010
3. Mohan S, Farley J, Baylink D (1995) Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging. Prog Growth Factor Res 6:465-473
4. Thoren M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Saaf M, Baylink DJ, Mohan S (1998) Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy. J Bone Miner Res 13:891-899
5. Jones J, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
6. Bouillon R (1991) Growth hormone and bone. Horm Res 36(suppl):49-55
7. Clemmons D, Van Wyk J (1984) Factors controlling blood concentrations of somatomedin C. Clin Endocrinol Metab 13:113-143
8. Nicholas V, Prewett A, Beltica P, Mohan S, Finkelman R, Baylink DJ, Farley AJ (1994) Age-related decreases of insulin-like growth factor-1 and transforming growth factor-b in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016
9. Donahue L, Hunter SJ, Sherblom AP, Rosen CJ (1990) Age-related changes in serum IGFBPs in women. J Clin Endocrinol Metab 71:575-579
10. Wuester C, Blum W, Schlemilch S, Ranke MB, Ziegler R (1993) Decreased insulin-like growth factors and IGF binding protein in osteoporosis. J Intern Med 234:249-255
11. Garnero P, Sornay-Rendu E, Delmas PD (2000) Low serum IGF-I and occurrence of osteoporotic fractures in postmenopausal women. Lancet 335:898-899
12. Campillo B, Paillaud E, Bones P, Noel M, Porquet D, Le Parco J (2000) Serum levels of insulin-like growth factor-1 in the three months following surgery for a hip fracture in elderly: relationship with nutritional status and inflammatory reaction. Clin Nutr 19:349-354
13. Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113-117
14. Langlois J, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PWF, Kiel DP (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: The Framingham Heart Study. J Clin Endocrinol Metab 83:4257-4262
15. Seck T, Scheidt-Nave C, Leidig-Bruckner G, Ziegler R, Pfeilschifter J (2001) Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women. Clin Endocrinol 55:101-106
16. Rosen C, Mohan S, Hunter SJ, Vereault D, Baylink DJ (1997) Seasonal changes in bone density and in serum IGFBP-4 levels are associated with calcium intake and parathyroid hormone (PTH) concentrations in elderly New England women (abstract). J Bone Miner Res 12(Suppl1): S166
17. Kassem M, Brixen K, Mosekilde L, Blum WF, Flyvbjerg A (1998) Effects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal women. Clin Endocrinol 49:747-756
18. Ueland T, Bollerslev J, Hansen TB, Ebbesen EN, Mosekilde L, Brixen K, Flyvbjerg A, Djoseland O (1999) Increased cortical bone content of insulin-like growth factors in acromegalic patients. J Clin Endocrinol Metab 84:123-127
19. Richman C, Baylink DJ, Lang K, Dony C, Mohan S (1999) Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140:4699-4705
20. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S (2001) Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81
21. Rosen C, Morrison A, Zhou H, Storm D, Hunter SJ, Musgrave K, Chen T, Wei W, Holick MF (1994) Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner 25:83-92
22. Kveiborg M, Flyvbjerg A, Rattan SIS, Kassem M (2000) Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions. Exp Gerontol 35:1061-1074
23. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP (2000) Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 15:710-720
24. Grogean T, Vereault D, Millard PS, Kiel DP, MacLean D, Orwoll E, Greenspan S, Rosen CJ (1997) A comparative analysis of methods to measure IGF-I in human serum. Endocrinol Metab 4:109-114
25. Kiel D, Puhl J, Rosen CJ, Berg K, Murphy JB, MacLean DB (1998) Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations. J Am Geriatr Soc 46:822-828
26. Mohan S, Libanati DC, Lang K, Srinivasan N, Baylink D (1995) Development, validation, and application of a radio-immunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab 80:2638-2645
27. Duan C, Liimatta MB, Bottum OL (1999) Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway. J Biol Chem 274:37147-37153